Analyst Ratings January 27, 2026

Canaccord Lifts USA Rare Earth Price Target to $33, Cites Improved Financing and Faster Timeline

Broker keeps Buy rating as proposed CHIPS Act loan and other funding reshuffle the company's capital picture

By Avery Klein USAR
Canaccord Lifts USA Rare Earth Price Target to $33, Cites Improved Financing and Faster Timeline
USAR

Canaccord Genuity raised its price target on USA Rare Earth Inc (NASDAQ: USAR) to $33.00 from $23.00 and kept a Buy rating after the company disclosed enhanced financing options. The broker flagged a proposed $1.3 billion senior secured loan through the CHIPS Act as a key factor behind the change, and said the improved funding profile supports a quicker operational schedule and a modest reduction in the firm's WACC assumption.

Key Points

  • Canaccord raised its price target on USA Rare Earth to $33.00 from $23.00 and retained a Buy rating.
  • A proposed $1.3 billion senior secured loan under the CHIPS Act and additional funding commitments improved the company’s financing outlook and supported a reduced WACC assumption from ~14% to 13%.
  • USA Rare Earth has a non-binding Letter of Intent with the U.S. Department of Commerce that outlines $277 million in federal funding plus a $1.3 billion senior secured loan, combined with $1.5 billion in private investment; Benchmark also raised its target to $45 amid capacity expansion plans.

Canaccord Genuity raised its price target for USA Rare Earth Inc (NASDAQ: USAR) to $33.00 from $23.00 on Tuesday, while maintaining a Buy rating. At the time of the update, USAR was trading at $26.72 and had an approximate market capitalization of $3.5 billion.

The analyst firm said the target increase reflects newly announced financing options that it expects will accelerate the company's planned operational timeline. Canaccord singled out a proposed $1.3 billion senior secured loan under the CHIPS Act as an important improvement to USA Rare Earth's capital structure. That financing development was among the drivers cited for the stock's notable market move - the company recorded a roughly 39% gain over the prior week.

As a result of the altered financing outlook, Canaccord trimmed its weighted average cost of capital (WACC) assumption for USA Rare Earth from roughly 14% to 13%. The broker also updated its financial models to incorporate what it views as a faster path to operations enabled by enhanced access to capital.

Analyst targets for the stock are widely dispersed. According to InvestingPro data cited by the reporting, target prices among analysts range from $15 to $45, underscoring the breadth of expectations in the market for USA Rare Earth's future performance.

Separately, the company has outlined a package of proposed federal and private funding in a non-binding Letter of Intent with the U.S. Department of Commerce under the CHIPS Program. That package, as described, would total $1.6 billion in proposed federal support and comprises $277 million in federal funding plus a $1.3 billion senior secured loan. The financing plan is paired with a $1.5 billion private investment the company has identified.

The reporting further notes that the Trump administration plans to invest $1.6 billion in USA Rare Earth, which would result in the government holding a 10% stake in the company. In reaction to these funding developments and the prospect of expanded output, Benchmark raised its own price target on USA Rare Earth from $15 to $45 and maintained a Buy rating, citing increased production capacity. That capacity is expected to double to 10,000 metric tons annually under the revised plans.

Operational progress also advanced on the project execution front. USA Rare Earth selected Fluor Corp and WSP Global Inc as its Engineering, Procurement, and Construction Management (EPCM) partners for the Round Top Rare Earth Project in Texas. The companies will support advancement of the Definitive Feasibility Study for the project, with commercial production on the timeline for late 2028.

Canaccord's upgrade and the surrounding financing announcements have been reflected in the market reaction, but the funding remains a set of proposed arrangements and the company continues to progress through development milestones tied to feasibility work and project execution.

Risks

  • The financing referenced includes a non-binding Letter of Intent, which means the proposed federal funding is not guaranteed and remains subject to final agreements - this uncertainty affects the materials and mining sectors tied to project development.
  • Production timing and commercial ramp are targeted for late 2028 but remain dependent on completing the Definitive Feasibility Study and securing final project execution, introducing schedule risk for capital-intensive mining and processing operations.
  • Analyst price targets are highly dispersed, ranging from $15 to $45, indicating significant valuation and outcome uncertainty that impacts equity investors and market participants in the materials and semiconductor supply chain sectors.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026